GITNUXREPORT 2026

Native American Health Disparities Statistics

Native Americans face severe and disproportionate health crises across multiple diseases.

Alexander Schmidt

Alexander Schmidt

Research Analyst specializing in technology and digital transformation trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

AI/AN cancer incidence rate is 327.8 per 100,000, similar to whites but mortality 13% higher (2014-2018)

Statistic 2

Liver cancer mortality in AI/AN is 3.3 times higher than whites (15.5 vs 4.7 per 100,000)

Statistic 3

Colorectal cancer death rate for AI/AN 20.6 per 100,000, 25% higher than whites

Statistic 4

Breast cancer mortality in AI/AN women 1.4 times whites (27.2 vs 19.5)

Statistic 5

Lung cancer incidence in AI/AN men 54.9 per 100,000, highest due to smoking

Statistic 6

Kidney cancer mortality 1.8 times higher in AI/AN (5.9 vs 3.3 per 100,000)

Statistic 7

Cervical cancer death rate 2.1 times whites in AI/AN women (4.9 vs 2.3)

Statistic 8

Prostate cancer incidence similar but stage-at-diagnosis later in AI/AN (45% regional)

Statistic 9

Pancreatic cancer mortality 1.3x higher (13.4 vs 10.3)

Statistic 10

In Northern Plains tribes, gallbladder cancer rates 5x national average

Statistic 11

AI/AN 5-year cancer survival 54% vs 67% whites

Statistic 12

Oral cancer death rate 1.5x higher (3.7 vs 2.5 per 100,000)

Statistic 13

HPV-related cancer incidence 1.7x whites in AI/AN women

Statistic 14

In Alaska Natives, nasopharyngeal cancer 10x higher

Statistic 15

Late-stage breast cancer diagnosis 50% more common in AI/AN

Statistic 16

Liver cancer in AI/AN linked to HCV, with 70% late diagnosis

Statistic 17

Colorectal screening rates 52% in AI/AN vs 68% whites (2020)

Statistic 18

Stomach cancer mortality 2.1x higher (7.0 vs 3.3 per 100,000)

Statistic 19

Multiple myeloma incidence 1.4x whites (7.9 vs 5.7)

Statistic 20

In Southwest, liver fluke-related cholangiocarcinoma elevated

Statistic 21

AI/AN cancer treatment delays average 30 days longer

Statistic 22

Bladder cancer mortality similar but 20% higher recurrence in AI/AN

Statistic 23

In urban AI/AN, cancer mortality 15% above rural peers

Statistic 24

Esophageal cancer death rate 1.6x whites (5.2 vs 3.3)

Statistic 25

Leukemia incidence 1.2x higher in AI/AN children

Statistic 26

Melanoma mortality lower but rising 5% annually in AI/AN

Statistic 27

Thyroid cancer incidence highest in AI/AN women (18.5 per 100,000)

Statistic 28

AI/AN age-adjusted heart disease death rate is 189.1 per 100,000, 1.2 times higher than whites (2018)

Statistic 29

Stroke mortality among AI/AN is 48.5 per 100,000, 1.3 times the white rate (2015-2019)

Statistic 30

AI/AN have hypertension prevalence of 34.1%, vs 30.2% U.S. adults, but poorer control (2017)

Statistic 31

Coronary heart disease hospitalization rates for AI/AN are 25% higher than whites (2016)

Statistic 32

In Alaska Natives, cardiovascular mortality is 20% higher than U.S. average (2019)

Statistic 33

AI/AN adults have 1.5 times higher prevalence of high cholesterol (39% vs 26%)

Statistic 34

Heart failure rates among AI/AN Medicare enrollees 1.4 times higher (2018)

Statistic 35

AI/AN women experience MI mortality 1.6 times higher than white women

Statistic 36

In Southwest tribes, rheumatic heart disease persists at 5-10 per 1,000, vs <1 nationally

Statistic 37

AI/AN have 40% higher rates of peripheral artery disease linked to CVD

Statistic 38

Smoking prevalence 31% in AI/AN contributes to 50% higher CVD death risk

Statistic 39

AI/AN youth have 2x higher congenital heart defects prevalence

Statistic 40

In Montana, AI/AN heart disease death rate 248 per 100,000 vs 180 whites (2019)

Statistic 41

Urban AI/AN CVD hospitalization 30% above national average (UIHI)

Statistic 42

AI/AN have lower statin prescription rates (45% vs 60% diabetics with CVD)

Statistic 43

Cerebrovascular disease death rate for AI/AN men 1.4x whites (65.2 vs 46.1)

Statistic 44

In IHS areas, 25% of AI/AN adults have uncontrolled hypertension

Statistic 45

AI/AN post-MI 30-day mortality 15% higher

Statistic 46

Atrial fibrillation prevalence 1.3x higher in AI/AN over 65

Statistic 47

In Oklahoma, AI/AN stroke rate 62 per 100,000 vs 38 whites

Statistic 48

AI/AN have 2x higher aortic aneurysm rupture rates

Statistic 49

CVD contributes to 24% of AI/AN deaths, vs 23% nationally but at younger ages

Statistic 50

AI/AN rural residents have 1.8x CVD mortality disparity

Statistic 51

Carotid artery stenosis screening underutilized in AI/AN (only 20% screened)

Statistic 52

In 2018, the age-adjusted diabetes prevalence among American Indians/Alaska Natives (AI/AN) was 14.5%, more than double the 7.1% rate for non-Hispanic whites

Statistic 53

AI/AN adults have a diabetes mortality rate 1.7 times higher than the general U.S. population (52.8 vs 31.1 per 100,000)

Statistic 54

Among AI/AN in Arizona, diabetes prevalence reached 19.2% in 2019, compared to 9.5% statewide

Statistic 55

End-stage renal disease due to diabetes is 3.8 times higher in AI/AN than in whites (2017 data)

Statistic 56

AI/AN youth aged 10-19 have a type 2 diabetes prevalence of 1.4%, over 3 times higher than white youth (0.4%)

Statistic 57

In the IHS service population, diabetes-related amputations occur at a rate 3-4 times higher than the U.S. average

Statistic 58

Pima Indians in Arizona have the highest diabetes prevalence globally at 38% in adults over 35

Statistic 59

AI/AN women have gestational diabetes rates 8.3 times higher than white women (8.4% vs 1.0%)

Statistic 60

Diabetes hospitalization rates for AI/AN are 2.3 times higher than for whites (2016-2018)

Statistic 61

In South Dakota, AI/AN diabetes death rate was 77.5 per 100,000 vs 22.4 for whites (2015-2019)

Statistic 62

AI/AN have diabetic retinopathy prevalence of 22%, double the U.S. average

Statistic 63

Among Navajo Nation, diabetes prevalence is 21.1% (2018 survey)

Statistic 64

AI/AN adults with diabetes have uncontrolled A1C (>9%) in 42% of cases vs 26% whites

Statistic 65

Diabetes contributes to 13% of AI/AN deaths under 65, vs 4% nationally

Statistic 66

In Alaska Natives, diabetes prevalence doubled from 5.7% in 1993 to 11.4% in 2017

Statistic 67

AI/AN Medicare beneficiaries have 50% higher rates of diabetes-related ER visits

Statistic 68

Type 1 diabetes incidence in AI/AN youth is 12.2 per 100,000, similar to whites but with higher complications

Statistic 69

In Oklahoma, AI/AN diabetes prevalence is 15.8% vs 10.2% non-Hispanic whites (BRFSS 2020)

Statistic 70

AI/AN with diabetes have 2.5 times higher risk of lower extremity amputation

Statistic 71

Urban AI/AN diabetes rate is 12.6%, 1.8 times national average (UIHI 2019)

Statistic 72

Diabetes is the 5th leading cause of death for AI/AN, with age-adjusted rate 2.1 times whites

Statistic 73

In Montana, AI/AN diabetes mortality is 58.3 per 100,000 vs 20.1 whites (2018)

Statistic 74

AI/AN adults report physical inactivity 1.5 times higher among diabetics (50% vs 33%)

Statistic 75

Diabetic ketoacidosis hospitalization rates 4 times higher in AI/AN youth

Statistic 76

In New Mexico, Pueblo Indians have 25% diabetes prevalence

Statistic 77

AI/AN diabetes patients have 30% lower statin use for cholesterol control

Statistic 78

From 2014-2018, AI/AN diabetes death rate increased 12%, vs 5% decline nationally

Statistic 79

AI/AN women with diabetes have 3.2 times higher preeclampsia risk

Statistic 80

In California, AI/AN diabetes prevalence 13.2% vs 8.9% whites (2019)

Statistic 81

AI/AN have 2.8 times higher prevalence of diabetic neuropathy

Statistic 82

Tuberculosus incidence in AI/AN 3.3 times U.S. rate (3.9 vs 1.2 per 100,000, 2020)

Statistic 83

COVID-19 death rate for AI/AN 2.1 times whites (254 vs 121 per 100,000, 2021)

Statistic 84

Hepatitis C prevalence 2.5% in AI/AN vs 1.0% whites (2015-2018)

Statistic 85

HIV diagnosis rate 1.3 times national average (8.1 per 100,000)

Statistic 86

Pneumococcal pneumonia hospitalization 2x higher in AI/AN (2018)

Statistic 87

Influenza mortality 1.7x whites during 2018-2019 season

Statistic 88

Chlamydia rates in AI/AN women 3.8x whites (1,098 vs 289 per 100,000, 2021)

Statistic 89

Gonorrhea incidence 4.5 times higher (652 vs 145 per 100,000)

Statistic 90

In Alaska Natives, pertussis outbreaks 10x national

Statistic 91

Syphilis rates 3.2x whites (42 vs 13 per 100,000, 2021)

Statistic 92

Lower respiratory infections death rate 1.4x higher (48 per 100,000)

Statistic 93

Hepatitis A outbreaks in AI/AN communities 5x impact (2016-2020)

Statistic 94

MRSA skin infections 2x prevalence in AI/AN (2019)

Statistic 95

In Navajo Nation, COVID positivity 35% higher (2020)

Statistic 96

Infant pertussis mortality 4x U.S. average in AI/AN

Statistic 97

Chronic hepatitis B 2.2% carrier rate in high-risk tribes

Statistic 98

Invasive Hib disease 3x higher pre-vaccine, persists in under-vaccinated areas

Statistic 99

In Montana reservations, TB rate 15 per 100,000 vs 0.5 state

Statistic 100

COVID vaccination hesitancy 40% in AI/AN vs 20% whites initially

Statistic 101

Sepsis hospitalization from infections 1.8x higher

Statistic 102

HPV prevalence 25% in AI/AN young adults vs 15% whites

Statistic 103

In urban AI/AN, STI rates 2.5x national (UIHI 2022)

Statistic 104

Meningococcal disease outbreaks 3x in AI/AN dorms

Statistic 105

Chronic viral hepatitis deaths 2x whites (2018)

Statistic 106

Respiratory syncytial virus hospitalization in AI/AN infants 2.2x

Statistic 107

In Southwest, Valley fever rates 5x non-Native

Statistic 108

Post-COVID long hauler symptoms 50% in AI/AN hospitalized

Statistic 109

AI/AN suicide rate is 3.5 times the national average (16.1 per 100,000 in 2019)

Statistic 110

AI/AN youth suicide death rate 2.5 times whites (10.1 vs 4.0 per 100,000, ages 10-24)

Statistic 111

22% of AI/AN adults report serious psychological distress vs 4% whites (2019 NSDUH)

Statistic 112

PTSD prevalence 15% in AI/AN veterans, 2x non-Native vets

Statistic 113

Depression rates 17.5% in AI/AN vs 6.6% whites (BRFSS 2018)

Statistic 114

AI/AN have highest suicide attempt rate (2.7%) among U.S. ethnic groups (ages 18+)

Statistic 115

In Alaska Native youth, suicide cluster rates reached 50 per 100,000 in some villages

Statistic 116

40% of AI/AN report frequent mental health distress (14+ days/month)

Statistic 117

Urban AI/AN anxiety disorder prevalence 28% vs 18% national (UIHI)

Statistic 118

AI/AN women suicide rate 5.6 per 100,000, 3.4x white women

Statistic 119

Only 17% of AI/AN with mental illness receive treatment vs 46% whites

Statistic 120

Bipolar disorder diagnosis 2x higher in AI/AN (4.2% vs 2.1%)

Statistic 121

In Navajo Nation, suicide ideations 25% among high schoolers

Statistic 122

AI/AN elderly depression 12% vs 7% whites, with higher suicide risk

Statistic 123

Schizophrenia prevalence 1.5% in AI/AN, undertreated

Statistic 124

Mental health hospitalization rates 2x higher but shorter stays in AI/AN

Statistic 125

AI/AN opioid misuse with mental illness 45% comorbidity

Statistic 126

Youth suicide prevention gaps: 60% of AI/AN schools lack counselors

Statistic 127

In South Dakota tribes, suicide rate 4x state average (42 per 100,000)

Statistic 128

AI/AN LGBTQ+ youth suicide attempt 40% vs 20% non-Native

Statistic 129

Historical trauma correlates with 30% higher PTSD in AI/AN

Statistic 130

Telepsychiatry access only 10% in rural AI/AN areas

Statistic 131

AI/AN overdose deaths with mental health dx 3x whites

Statistic 132

Seasonal affective disorder 25% in Alaska Natives

Statistic 133

AI/AN children ADHD diagnosis 14%, treatment 60% gap

Statistic 134

Suicide by firearm 50% of AI/AN suicides, highest method

Statistic 135

Alcohol use disorder 15% in AI/AN with depression comorbidity

Statistic 136

AI/AN veterans PTSD suicide risk 4x general population

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Behind every statistic lies a human story, and the story of health among American Indians and Alaska Natives is one of alarming and persistent disparity.

Key Takeaways

  • In 2018, the age-adjusted diabetes prevalence among American Indians/Alaska Natives (AI/AN) was 14.5%, more than double the 7.1% rate for non-Hispanic whites
  • AI/AN adults have a diabetes mortality rate 1.7 times higher than the general U.S. population (52.8 vs 31.1 per 100,000)
  • Among AI/AN in Arizona, diabetes prevalence reached 19.2% in 2019, compared to 9.5% statewide
  • AI/AN age-adjusted heart disease death rate is 189.1 per 100,000, 1.2 times higher than whites (2018)
  • Stroke mortality among AI/AN is 48.5 per 100,000, 1.3 times the white rate (2015-2019)
  • AI/AN have hypertension prevalence of 34.1%, vs 30.2% U.S. adults, but poorer control (2017)
  • AI/AN cancer incidence rate is 327.8 per 100,000, similar to whites but mortality 13% higher (2014-2018)
  • Liver cancer mortality in AI/AN is 3.3 times higher than whites (15.5 vs 4.7 per 100,000)
  • Colorectal cancer death rate for AI/AN 20.6 per 100,000, 25% higher than whites
  • AI/AN suicide rate is 3.5 times the national average (16.1 per 100,000 in 2019)
  • AI/AN youth suicide death rate 2.5 times whites (10.1 vs 4.0 per 100,000, ages 10-24)
  • 22% of AI/AN adults report serious psychological distress vs 4% whites (2019 NSDUH)
  • Tuberculosus incidence in AI/AN 3.3 times U.S. rate (3.9 vs 1.2 per 100,000, 2020)
  • COVID-19 death rate for AI/AN 2.1 times whites (254 vs 121 per 100,000, 2021)
  • Hepatitis C prevalence 2.5% in AI/AN vs 1.0% whites (2015-2018)

Native Americans face severe and disproportionate health crises across multiple diseases.

Cancer

  • AI/AN cancer incidence rate is 327.8 per 100,000, similar to whites but mortality 13% higher (2014-2018)
  • Liver cancer mortality in AI/AN is 3.3 times higher than whites (15.5 vs 4.7 per 100,000)
  • Colorectal cancer death rate for AI/AN 20.6 per 100,000, 25% higher than whites
  • Breast cancer mortality in AI/AN women 1.4 times whites (27.2 vs 19.5)
  • Lung cancer incidence in AI/AN men 54.9 per 100,000, highest due to smoking
  • Kidney cancer mortality 1.8 times higher in AI/AN (5.9 vs 3.3 per 100,000)
  • Cervical cancer death rate 2.1 times whites in AI/AN women (4.9 vs 2.3)
  • Prostate cancer incidence similar but stage-at-diagnosis later in AI/AN (45% regional)
  • Pancreatic cancer mortality 1.3x higher (13.4 vs 10.3)
  • In Northern Plains tribes, gallbladder cancer rates 5x national average
  • AI/AN 5-year cancer survival 54% vs 67% whites
  • Oral cancer death rate 1.5x higher (3.7 vs 2.5 per 100,000)
  • HPV-related cancer incidence 1.7x whites in AI/AN women
  • In Alaska Natives, nasopharyngeal cancer 10x higher
  • Late-stage breast cancer diagnosis 50% more common in AI/AN
  • Liver cancer in AI/AN linked to HCV, with 70% late diagnosis
  • Colorectal screening rates 52% in AI/AN vs 68% whites (2020)
  • Stomach cancer mortality 2.1x higher (7.0 vs 3.3 per 100,000)
  • Multiple myeloma incidence 1.4x whites (7.9 vs 5.7)
  • In Southwest, liver fluke-related cholangiocarcinoma elevated
  • AI/AN cancer treatment delays average 30 days longer
  • Bladder cancer mortality similar but 20% higher recurrence in AI/AN
  • In urban AI/AN, cancer mortality 15% above rural peers
  • Esophageal cancer death rate 1.6x whites (5.2 vs 3.3)
  • Leukemia incidence 1.2x higher in AI/AN children
  • Melanoma mortality lower but rising 5% annually in AI/AN
  • Thyroid cancer incidence highest in AI/AN women (18.5 per 100,000)

Cancer Interpretation

When you see that a population's cancer incidence is nearly identical to the national average, yet they face dramatically higher death rates across nearly every site, from later-stage diagnoses and treatment delays to crumbling screening infrastructure, it paints a chillingly clear picture: our healthcare systems are failing at delivering equitable survival.

Cardiovascular Disease

  • AI/AN age-adjusted heart disease death rate is 189.1 per 100,000, 1.2 times higher than whites (2018)
  • Stroke mortality among AI/AN is 48.5 per 100,000, 1.3 times the white rate (2015-2019)
  • AI/AN have hypertension prevalence of 34.1%, vs 30.2% U.S. adults, but poorer control (2017)
  • Coronary heart disease hospitalization rates for AI/AN are 25% higher than whites (2016)
  • In Alaska Natives, cardiovascular mortality is 20% higher than U.S. average (2019)
  • AI/AN adults have 1.5 times higher prevalence of high cholesterol (39% vs 26%)
  • Heart failure rates among AI/AN Medicare enrollees 1.4 times higher (2018)
  • AI/AN women experience MI mortality 1.6 times higher than white women
  • In Southwest tribes, rheumatic heart disease persists at 5-10 per 1,000, vs <1 nationally
  • AI/AN have 40% higher rates of peripheral artery disease linked to CVD
  • Smoking prevalence 31% in AI/AN contributes to 50% higher CVD death risk
  • AI/AN youth have 2x higher congenital heart defects prevalence
  • In Montana, AI/AN heart disease death rate 248 per 100,000 vs 180 whites (2019)
  • Urban AI/AN CVD hospitalization 30% above national average (UIHI)
  • AI/AN have lower statin prescription rates (45% vs 60% diabetics with CVD)
  • Cerebrovascular disease death rate for AI/AN men 1.4x whites (65.2 vs 46.1)
  • In IHS areas, 25% of AI/AN adults have uncontrolled hypertension
  • AI/AN post-MI 30-day mortality 15% higher
  • Atrial fibrillation prevalence 1.3x higher in AI/AN over 65
  • In Oklahoma, AI/AN stroke rate 62 per 100,000 vs 38 whites
  • AI/AN have 2x higher aortic aneurysm rupture rates
  • CVD contributes to 24% of AI/AN deaths, vs 23% nationally but at younger ages
  • AI/AN rural residents have 1.8x CVD mortality disparity
  • Carotid artery stenosis screening underutilized in AI/AN (only 20% screened)

Cardiovascular Disease Interpretation

These statistics paint a grim portrait of a system failing Native communities, where the heart of the issue isn't just biology but a legacy of inequity that leaves cardiovascular health broken treaty by broken treaty.

Diabetes

  • In 2018, the age-adjusted diabetes prevalence among American Indians/Alaska Natives (AI/AN) was 14.5%, more than double the 7.1% rate for non-Hispanic whites
  • AI/AN adults have a diabetes mortality rate 1.7 times higher than the general U.S. population (52.8 vs 31.1 per 100,000)
  • Among AI/AN in Arizona, diabetes prevalence reached 19.2% in 2019, compared to 9.5% statewide
  • End-stage renal disease due to diabetes is 3.8 times higher in AI/AN than in whites (2017 data)
  • AI/AN youth aged 10-19 have a type 2 diabetes prevalence of 1.4%, over 3 times higher than white youth (0.4%)
  • In the IHS service population, diabetes-related amputations occur at a rate 3-4 times higher than the U.S. average
  • Pima Indians in Arizona have the highest diabetes prevalence globally at 38% in adults over 35
  • AI/AN women have gestational diabetes rates 8.3 times higher than white women (8.4% vs 1.0%)
  • Diabetes hospitalization rates for AI/AN are 2.3 times higher than for whites (2016-2018)
  • In South Dakota, AI/AN diabetes death rate was 77.5 per 100,000 vs 22.4 for whites (2015-2019)
  • AI/AN have diabetic retinopathy prevalence of 22%, double the U.S. average
  • Among Navajo Nation, diabetes prevalence is 21.1% (2018 survey)
  • AI/AN adults with diabetes have uncontrolled A1C (>9%) in 42% of cases vs 26% whites
  • Diabetes contributes to 13% of AI/AN deaths under 65, vs 4% nationally
  • In Alaska Natives, diabetes prevalence doubled from 5.7% in 1993 to 11.4% in 2017
  • AI/AN Medicare beneficiaries have 50% higher rates of diabetes-related ER visits
  • Type 1 diabetes incidence in AI/AN youth is 12.2 per 100,000, similar to whites but with higher complications
  • In Oklahoma, AI/AN diabetes prevalence is 15.8% vs 10.2% non-Hispanic whites (BRFSS 2020)
  • AI/AN with diabetes have 2.5 times higher risk of lower extremity amputation
  • Urban AI/AN diabetes rate is 12.6%, 1.8 times national average (UIHI 2019)
  • Diabetes is the 5th leading cause of death for AI/AN, with age-adjusted rate 2.1 times whites
  • In Montana, AI/AN diabetes mortality is 58.3 per 100,000 vs 20.1 whites (2018)
  • AI/AN adults report physical inactivity 1.5 times higher among diabetics (50% vs 33%)
  • Diabetic ketoacidosis hospitalization rates 4 times higher in AI/AN youth
  • In New Mexico, Pueblo Indians have 25% diabetes prevalence
  • AI/AN diabetes patients have 30% lower statin use for cholesterol control
  • From 2014-2018, AI/AN diabetes death rate increased 12%, vs 5% decline nationally
  • AI/AN women with diabetes have 3.2 times higher preeclampsia risk
  • In California, AI/AN diabetes prevalence 13.2% vs 8.9% whites (2019)
  • AI/AN have 2.8 times higher prevalence of diabetic neuropathy

Diabetes Interpretation

These statistics aren't just a disparity; they are the relentless arithmetic of historical trauma, systemic neglect, and a fractured healthcare ecosystem, written on the bodies of Native people.

Infectious Diseases

  • Tuberculosus incidence in AI/AN 3.3 times U.S. rate (3.9 vs 1.2 per 100,000, 2020)
  • COVID-19 death rate for AI/AN 2.1 times whites (254 vs 121 per 100,000, 2021)
  • Hepatitis C prevalence 2.5% in AI/AN vs 1.0% whites (2015-2018)
  • HIV diagnosis rate 1.3 times national average (8.1 per 100,000)
  • Pneumococcal pneumonia hospitalization 2x higher in AI/AN (2018)
  • Influenza mortality 1.7x whites during 2018-2019 season
  • Chlamydia rates in AI/AN women 3.8x whites (1,098 vs 289 per 100,000, 2021)
  • Gonorrhea incidence 4.5 times higher (652 vs 145 per 100,000)
  • In Alaska Natives, pertussis outbreaks 10x national
  • Syphilis rates 3.2x whites (42 vs 13 per 100,000, 2021)
  • Lower respiratory infections death rate 1.4x higher (48 per 100,000)
  • Hepatitis A outbreaks in AI/AN communities 5x impact (2016-2020)
  • MRSA skin infections 2x prevalence in AI/AN (2019)
  • In Navajo Nation, COVID positivity 35% higher (2020)
  • Infant pertussis mortality 4x U.S. average in AI/AN
  • Chronic hepatitis B 2.2% carrier rate in high-risk tribes
  • Invasive Hib disease 3x higher pre-vaccine, persists in under-vaccinated areas
  • In Montana reservations, TB rate 15 per 100,000 vs 0.5 state
  • COVID vaccination hesitancy 40% in AI/AN vs 20% whites initially
  • Sepsis hospitalization from infections 1.8x higher
  • HPV prevalence 25% in AI/AN young adults vs 15% whites
  • In urban AI/AN, STI rates 2.5x national (UIHI 2022)
  • Meningococcal disease outbreaks 3x in AI/AN dorms
  • Chronic viral hepatitis deaths 2x whites (2018)
  • Respiratory syncytial virus hospitalization in AI/AN infants 2.2x
  • In Southwest, Valley fever rates 5x non-Native
  • Post-COVID long hauler symptoms 50% in AI/AN hospitalized

Infectious Diseases Interpretation

If infectious diseases were holding auditions for their favorite host, they'd apparently see America's first peoples not as a population but as a perpetually open casting call, a grim reality born of systemic neglect and not, as some might lazily assume, any inherent vulnerability.

Mental Health

  • AI/AN suicide rate is 3.5 times the national average (16.1 per 100,000 in 2019)
  • AI/AN youth suicide death rate 2.5 times whites (10.1 vs 4.0 per 100,000, ages 10-24)
  • 22% of AI/AN adults report serious psychological distress vs 4% whites (2019 NSDUH)
  • PTSD prevalence 15% in AI/AN veterans, 2x non-Native vets
  • Depression rates 17.5% in AI/AN vs 6.6% whites (BRFSS 2018)
  • AI/AN have highest suicide attempt rate (2.7%) among U.S. ethnic groups (ages 18+)
  • In Alaska Native youth, suicide cluster rates reached 50 per 100,000 in some villages
  • 40% of AI/AN report frequent mental health distress (14+ days/month)
  • Urban AI/AN anxiety disorder prevalence 28% vs 18% national (UIHI)
  • AI/AN women suicide rate 5.6 per 100,000, 3.4x white women
  • Only 17% of AI/AN with mental illness receive treatment vs 46% whites
  • Bipolar disorder diagnosis 2x higher in AI/AN (4.2% vs 2.1%)
  • In Navajo Nation, suicide ideations 25% among high schoolers
  • AI/AN elderly depression 12% vs 7% whites, with higher suicide risk
  • Schizophrenia prevalence 1.5% in AI/AN, undertreated
  • Mental health hospitalization rates 2x higher but shorter stays in AI/AN
  • AI/AN opioid misuse with mental illness 45% comorbidity
  • Youth suicide prevention gaps: 60% of AI/AN schools lack counselors
  • In South Dakota tribes, suicide rate 4x state average (42 per 100,000)
  • AI/AN LGBTQ+ youth suicide attempt 40% vs 20% non-Native
  • Historical trauma correlates with 30% higher PTSD in AI/AN
  • Telepsychiatry access only 10% in rural AI/AN areas
  • AI/AN overdose deaths with mental health dx 3x whites
  • Seasonal affective disorder 25% in Alaska Natives
  • AI/AN children ADHD diagnosis 14%, treatment 60% gap
  • Suicide by firearm 50% of AI/AN suicides, highest method
  • Alcohol use disorder 15% in AI/AN with depression comorbidity
  • AI/AN veterans PTSD suicide risk 4x general population

Mental Health Interpretation

These statistics are not a collection of abstract data points but the quantifiable echoes of historical trauma, where the shattered promises and severed ties of the past continue to fracture the present, leaving an entire people battling a silent epidemic of grief with tragically few lifelines.

Sources & References